Mickey Maurer’s [Nov. 26] commentary details a very rosy outlook for the future of Endocyte, the Indiana biopharmaceutical company. His clear message is, he believes the stock is going up and readers should get in now.
I have no interest in Endocyte nor do I own any stock in the company. I just question how a rich guy who owns his own newspaper can use it to “pump” a stock he owns. Seems like a great way for Maurer to create buying interest in a stock after he has his shares.